UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations
July 27 2017 - 9:37PM
Business Wire
Girard Gibbs LLP is investigating potential claims on behalf of
investors of United Therapeutics Corporation (NASDAQ:UTHR)
regarding possible securities law violations.
To speak with a securities attorney regarding this class
action lawsuit investigation, click here.
On July 27, 2017, the pulmonary arterial hypertension drug maker
disclosed that it has set aside $210 million in connection to a
possible settlement with the U.S. Department of Justice concerning
alleged violations of the federal False Claims Act and
anti-kickback laws. The DOJ previously subpoenaed United
Therapeutics for information about its contributions to non-profit
organizations that provide financial assistance to patients with
out-of-pocket drug costs. The company stated that it expects any
settlement would also include a corporate integrity agreement, and
the company may incur significant future costs to comply with that
agreement.
On this news, United Therapeutics’ share price fell $6.30, or
4.79%, to close at $125.10 on July 27, 2017.
If you purchased or acquired shares of United Therapeutics
Corporation and would like to speak privately with a securities
attorney to contribute to or learn more about the investigation,
visit our website or contact the securities team directly at (800)
254-9493.
Girard Gibbs LLP is one of the nation’s leading firms
representing individual and institutional investors
in securities litigation to correct abusive corporate
governance practices, breaches of fiduciary duty, and proxy
violations. The firm has recovered over a billion dollars for its
clients against some of the world’s largest corporations, and has
earned Tier-1 rankings and been named in the U.S. Lawyers –
Best Law Firms list for five consecutive years.
This press release may constitute Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170727006727/en/
Girard Gibbs LLPEileen Epstein,
510-350-9728EJE@CLASSLAWGROUP.COM
United Therapeutics (NASDAQ:UTHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
United Therapeutics (NASDAQ:UTHR)
Historical Stock Chart
From Apr 2023 to Apr 2024